1.Clinical analysis of 42 cases of pregnancy complicated with severe hepatitis
Clinical Medicine of China 2014;30(9):961-963
Objective To investigate the clinical features of pregnancy complicated severe hepatitis and summarize experience in diagnosis and treatment so as to decrease maternal mortality.Methods Forty-two cases of pregnant women with severe hepatitis in the hospital were retrospectively analyzed.According to the outcome,all subjects were divided into death group(27 cased) and survival group(15 cases).Clinical data including viral markers,clinical manifestations,blood biochemistry,clinical treatment and pregnancy outcomes were recorded.Results (1) Pathogen examination showed that the major infection was hepatitis B virus (HBV),accounting for 64.29% (27/42).(2) The first symptoms was gastrointestinal symptoms,accounting for 73.81% (31/42).(3) The level of serum albumin,cholesterin (CH) and cholinesterase (CHE) in survival group were (29.91 ± 6.78) g/L,(2.80 ± 1.02) μmol/L and (5 399.4 ± 1 096.5) U/L respectively,significantly higher than that in death group((25.14 ± 7.36) g/L,(1.73 ± 0.77) μmol/L,(3423.6 ± 1102.7) U/L respectively).The serum creatinine(SCr) and prothrombin time (PT) levels in survival group were (83.06 ± 47.23) μ mol/L,(18.98 ± 6.72) s,lower than that in death group ((231.54 ± 58.90) μmol/L,(44.16 ± 5.38) s).The differences were statistically significant (t =2.07,3.84,5.57,8.37,13.29 ; P < 0.05 or P < 0.001).(4) The mortality rate of patients who chose pregnancy termination was 31.58% (6/19),lower than the overall average mortality rate 64.29% (27/42) and the difference was statistically significant (x2 =5.636,P =0.018).Conclusion HBV infection is the main reason for pregnant women with severe hepatitis.Gastrointestinal symptoms is the main symptom.Serum albumin,SCr,PT,serum CH and CHE can be regarded as prognostic indicators of the disease.Active comprehensive treatment and timely pregnancy termination can reduce maternal mortality.
2.Practice and suggestions for the reform of drug and medical service separation reform and drug zero-profit policy in Wuhu
Chinese Journal of Hospital Administration 2013;29(10):729-732
The drug and medical consumables management center in Wuhu features the operational mechanism separating the decision-making power of drug purchasing,the executive power and the supervision power.This practice terminates the interest chain previously found between medicine suppliers with hospitals,pharmacies and doctors,creating the Wuhu Model of drug and medical service separation at public hospitals.The drug zero-profit policy reshapes the drug supply system and the existing compensation mechanism of public hospitals,further defining the Wuhu Model.This model is paving the way for the same reform to be carried out nationwide.
3.Detachment and return of pharmacies of public hospitals in Wuhu amid the drug and medical service separation reform and the outcomes
Chinese Journal of Hospital Administration 2013;29(10):733-737
The separation of drug and medical service is key to alleviating the social problem of high medical expenses,and the top thing to do is to cut off the profit link found in the drugs purchase and sales interests chain.Pharmacies of the hospital are found to play a crucial role in this chain,as they not only take part in the decision-making of drug purchase but also directly purchase and dispense drugs.Wuhu has established the Medicine and Medical Consumables Management Center,which directly regulates the pharmacies and detach them from this chain,weakening their rent-seeking power.Practices of this reform found the pharmacies no longer playing a dominant role in drug purchase/dispensation on one hand,and yet less incentives of the pharmacies due to management by the Center on the other,resulting in poorer pharmaceutical management of the hospital as a result.In this consideration,pharmacies have experienced a detachment and return process from their hospital in the reform of drug and medical service separation in Wuhu.Experiences prove the correct way out is to guide the pharmacies to upgrade from logistics in drug supply to innovated services,thus better serving hospital management.
4.Clinical observation of adefovir dipivoxil combined with Anluohuaxian pill in the treatment of chronic hepati- tis B cirrhosis
Chinese Journal of Primary Medicine and Pharmacy 2014;(5):658-659,660
Objective To explore the clinical effect of adenovirus dipivoxil combined with Anluohuaxian pill in the treatment of chronic hepatitis B cirrhosis .Methods 98 patients with chronic hepatitis B liver cirrhosis were randomly divided into the two groups .49 cases in the control group were treated with adenovirus dipivoxil ,and 49 ca-ses in the observation group were given adenovirus dipivoxil combined with Anluohuaxian pill .The clinical effect of two groups was observed .Results The total effective rate of the observation group was 92.9%,which was significant-ly higher than 69.4% of the control group (χ2 =9.37,P<0.05).Before treatment,the alanine aminotransferase (ALT),hyaluronic acid (HA) and albumin/globulin (A/G) between the observation group and the control group had no significant differences (t=0.213 1,1.212 2,0.403 2,all P>0.05).After treatment,the ALT,HA and A/G of the two groups were significantly improved compared with those before treatment ,the improvement of the observation group was better than control group ,the difference was statistically significant ( t=11.302 1,9.012 1,7.312 4,all P<0.05).Conclusion In clinical practice,adenovirus dipivoxil combined with Anluohuaxian pill in the treatment of patients with chronic hepatitis B cirrhosis has good therapeutic effect ,it can improve the clinical symptoms and pa-tients'liver function ,so as to improve the liver detoxification function and the clinical treatment effect ,which worthy of clinical application and promotion .
6.Effect of SP on Electroactivities of Thermo-Estradiol Related Sensitive Neurons in PO/AH of Rats
Journal of China Medical University 2001;30(1):22-24
Objective: The aim of this study was designed to certify the effects of substance P(SP) on thermo-gonohormonal neuron. Methods: We used the technique of extracellular microelectrode recording, and examined the effects of intravenously injections of SP on electroactiveties of thermo-gonohormonal neurons in PO/AH of rats. Results: Total of 9 warm-estradiol sensitive and 4 cold-estradiol sensitive neurons were recorded in PO/AH, where estradiol excited electroactivities of the warm-estradiol sensitive neurons but inhibited those of the cold-estradiol sensitive ones. While SP reversed the effects of estradiol bezonate on the above mentioned neurons. Conclusion: From our results and related data we may draw conclusions that the thermoregulatory effects of SP may be functioned via hermo-gonohormonal neuron.
7.Analysis of a survey on status of iodine content in drinking water, edible salt and urine of children aged 8 -10 in Qingdao in 2008 - 2009
Chinese Journal of Endemiology 2011;30(6):663-666
Objectives To identify the status of iodine content in drinking water,edible salt and urine of children aged 8- 10 after implementing every village project in Qingdao for providing basic reference for government's decision-making.Methods From March 2008 to July 2009,residents' living and drinking water samples were collected in 12 districts and counties of Qingdao,and iodide content was measured by cerous sulfate catalytic spectrophotometry.Urine samples of children aged from 8 to 10 were collected,in which the iodide content was quantitative tested by arsenic cerium catalytic spectrophotometry.Samples of household edible salt were collected to determine iodide content by direct titration.Results A total of 5067 water samples were measured,the median iodine content of water was 7.35 μg/L.A total of 1182 urine samples of children aged 8 - 10 were tested,and the urinary iodine content ranged from 4.6 μg/L to 5995.3 μg/L with a median of 200.6 μg/L.Besides,3504 household salt samples were tested,and the percentages of non-iodized salt,iodized salt and qualified iodized salt were 1.74%(61/3504),98.26%(3443/3504) and 96.32%(3375/3504),respectively.Conclusions Qingdao is situated in environmental iodine deficient area,and the iodine nutritional status of residents is appropriate owing to the implementation of universal salt iodization policy in Qingdao region.Comprehensive prevention and control measures to iodine deficiency disorders,including marketing iodized salt,should be implemented continually.
9.Changes of plasma brain natriuretic peptide and its clinical significance in patients with atrial fibrillation
Chinese Journal of General Practitioners 2008;7(7):456-458
Objective To study the changes of plasma brain natriuretic peptide(BNP)level in patients with atrial fibrillation(AF),and explore the relationship between plasma level of BNP and paroxysmal AF,persistent AF,rheumatic AF and non-rheumatic AF.Methods In total,158 outpatients and inpatients diagnosed as heart diseases were selected from the Affiliated Hospital of Inner Mongolia Medical College during October 2005 to January 2007,83 with AF and 75 without AF.Their cardiac function Was evaluated according to the classification system of the New York Heart Association(NYHA)in the United States.Plasma level of BNP was measured with bi-monoclonal antibody microparticulate enzyme immunoassay(MEIA).Results Plasma BNP level was significantly higher in AF group[(112±75)ng/L]than that in non-AF group[(39±26)ng/L,P<0.05]with same ventricular function.No significant difference in plasma level of BNP between the groups with paroxysmal AF[(113±84)ng/L]and with persistent AF[(110±69)ng/L]was found.Plasma level of BNP Was(84±73)ng/L in the group with rheumatic valvular AF,not significantly different from that in non-valvular AF[(117±76)ng/L,P>0.05].Conclusion Plasma BNP level is higher in AF group than that in non-AF group,but no significant difference in plasma BNP level between patients with paroxysmal AF,persistent AF,rheumatic valvular AF and non-rheumatic AF,under same ventricular function,was found.
10.A case report of Kasabach-Merritt syndrome.
Chinese Journal of Contemporary Pediatrics 2006;8(3):255-256
Female
;
Hemangioma
;
therapy
;
Humans
;
Infant, Newborn
;
Syndrome
;
Thrombocytopenia
;
therapy